BUSA - ETF AI Analysis

Top Page

Brandes U.S. Value ETF (BUSA)

Rating:69Neutral

Price Target:―

The Brandes U.S. Value ETF (BUSA) demonstrates solid overall quality, driven by strong contributions from top holdings like Alphabet (GOOG), which benefits from robust growth in AI and cloud services, efficient operations, and a strong balance sheet. Merck (MRK) also supports the fund with its strong financial performance and strategic investments, though caution is advised due to potential overbought conditions. However, weaker holdings like Becton Dickinson (BDX), which faces challenges in key markets and bearish technical trends, may have slightly weighed on the ETF's overall rating. A potential risk for the fund is its exposure to financial sector companies, some of which face challenges related to leverage and cash flow management.

Positive Factors

Strong Financial Holdings

Top financial stocks like Citigroup and Wells Fargo have delivered strong year-to-date gains, supporting the ETF's performance.

Sector Diversification

The ETF is spread across ten sectors, reducing the risk of being overly dependent on any single industry.

Healthy Year-to-Date Performance

The fund has shown solid performance so far this year, which may appeal to investors seeking steady growth.

Negative Factors

Underperforming Health Care Stocks

Key health care holdings like Merck and Pfizer have lagged, which could drag on the ETF's overall returns.

High U.S. Concentration

With nearly all assets invested in U.S. companies, the ETF lacks exposure to international markets, limiting geographic diversification.

Moderate Expense Ratio

The fund's expense ratio is higher than some low-cost ETFs, which could eat into long-term returns for investors.

BUSA vs. SPDR S&P 500 ETF (SPY)

AUM268.30M

RegionNorth America

Expense Ratio0.60%

Beta0.73

IssuerBrandes

Inception DateOct 03, 2023

Dividend Yield1.5%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume26,542

30 Day Avg. Volume23,197

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

39.96

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering64

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

BUSA Summary

The Brandes U.S. Value ETF (Ticker: BUSA) is an investment fund that focuses on U.S. companies that are considered undervalued, meaning their stock prices are lower than what the fund managers believe they are worth. It includes a mix of industries like healthcare, financials, and technology, with well-known companies such as Merck and Bank of America among its top holdings. Investors might consider BUSA for potential long-term growth by targeting stocks that could rebound in value over time. However, new investors should be aware that the fund’s performance can fluctuate with the overall market, and its focus on undervalued stocks may take time to show results.

How much will it cost me?The Brandes U.S. Value ETF (BUSA) has an expense ratio of 0.6%, meaning you’ll pay $6 per year for every $1,000 invested. This is higher than average because it is actively managed, with experts selecting undervalued stocks rather than following a passive index.

What would affect this ETF?The Brandes U.S. Value ETF could benefit from a recovery in undervalued sectors like Financials and Health Care, especially if economic conditions improve or interest rates stabilize, supporting growth in these industries. However, rising interest rates or regulatory changes in key sectors like Technology and Energy could negatively impact some of its top holdings, such as Bank of America and Chevron. The ETF's focus on U.S. equities means it is sensitive to domestic economic trends and policy shifts.

BUSA Top 10 Holdings

The Brandes U.S. Value ETF leans heavily into health care and financials, with these two sectors making up nearly half of its portfolio. Cardinal Health is a standout performer, riding bullish momentum thanks to strong earnings and cash flow, while Alphabet’s robust growth in AI and cloud services adds a tech-driven boost. On the flip side, Chevron’s recent struggles with declining cash flow and Textron’s mixed performance have weighed on the fund. With its U.S.-focused, value-oriented strategy, this ETF is a bet on undervalued opportunities, though sector concentration could amplify risks.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
MRK	Merck & Company	3.22%	$8.45M	$259.69B	2.94%	76 Outperform
GOOG	Alphabet Class C	2.79%	$7.32M	$3.86T	87.86%	82 Outperform
BAC	Bank of America	2.69%	$7.06M	$386.96B	11.53%	70 Outperform
C	Citigroup	2.64%	$6.92M	$183.40B	44.63%	67 Neutral
TXT	Textron	2.51%	$6.59M	$14.63B	-3.02%	67 Neutral
CAH	Cardinal Health	2.42%	$6.36M	$50.64B	74.36%	64 Neutral
WFC	Wells Fargo	2.36%	$6.20M	$268.58B	12.33%	76 Outperform
HCA	HCA Healthcare	2.34%	$6.15M	$117.47B	57.31%	76 Outperform
BDX	Becton Dickinson	2.30%	$6.03M	$55.34B	-12.65%	64 Neutral
PFE	Pfizer	2.28%	$5.99M	$146.18B	-1.91%	68 Neutral

BUSA Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

34.83

Positive

100DMA

34.37

Positive

200DMA

33.17

Positive

Market Momentum

MACD

0.13

Negative

RSI

63.51

Neutral

STOCH

88.73

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BUSA, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 34.83, equal to the 50-day MA of 34.83, and equal to the 200-day MA of 33.17, indicating a bullish trend. The MACD of 0.13 indicates Negative momentum. The RSI at 63.51 is Neutral, neither overbought nor oversold. The STOCH value of 88.73 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BUSA.

BUSA Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
BUSA	―	―	$268.30M	0.60%	―
VFVA	―	―	$719.00M	0.13%	―
LSVD	―	―	$536.59M	0.40%	―
QVAL	―	―	$428.14M	0.29%	―
AIVL	―	―	$381.04M	0.38%	―
GVLU	―	―	$204.39M	0.50%	―

Performance Comparison

BUSA

Brandes U.S. Value ETF

35.77

2.55

7.68%

VFVA

Vanguard U.S. Value Factor ETF

―

LSVD

LSV Disciplined Value ETF

―

QVAL

Alpha Architect U.S. Quantitative Value ETF

―

AIVL

WisdomTree U.S. AI Enhanced Value Fund

―

GVLU

Gotham 1000 Value ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents